Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

Bristol-Myers Squibb Company Celegne Contingent Value Rights (CELG.R : NYE)

Sector: Healthcare

Close
(03-27-2026)
$0.10
Change
$0.00 (0.40%)
Volume 11,702
Open $0.09
Day Range $0.09 - $0.10
52 Week Low $0.02
52 Week High $0.27
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $205,194,413
Shares Outstanding 2,041,735,455
Book Value per Share $0.01
Earnings per Share $3.46
Period
Loading......
Loading......

Legend

Bristol-Myers Squibb Company Celegne Contingent Value Rights

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
March 27, 2026 0.10
$0.00 (0.40%)
March 26, 2026 0.10
$0.00 (0.10%)
March 25, 2026 0.10
-$0.02 (-13.12%)
March 24, 2026 0.12
-$0.01 (-11.39%)
March 23, 2026 0.13
-$0.01 (-8.46%)
March 20, 2026 0.14
$0.03 (29.00%)
March 19, 2026 0.11
-$0.02 (-15.32%)
March 18, 2026 0.13
-$0.01 (-6.21%)
March 17, 2026 0.14
$0.01 (4.92%)
March 16, 2026 0.13
$0.00 (0.38%)
March 13, 2026 0.13
$0.01 (9.49%)
March 12, 2026 0.12
$0.02 (15.09%)
March 11, 2026 0.10
$0.00 (-3.83%)
March 10, 2026 0.11
$0.00 (3.33%)
March 09, 2026 0.11
-$0.01 (-12.43%)
March 06, 2026 0.12
-$0.06 (-31.84%)
March 05, 2026 0.18
$0.02 (10.84%)
March 04, 2026 0.16
$0.01 (5.80%)
March 03, 2026 0.15
$0.00 (1.21%)
March 02, 2026 0.15
$0.05 (51.69%)
February 27, 2026 0.10
-$0.01 (-10.86%)
February 26, 2026 0.11
$0.00 (3.79%)
February 25, 2026 0.11
$0.00 (-3.91%)
February 24, 2026 0.11
$0.02 (29.07%)
February 23, 2026 0.09
-$0.01 (-10.46%)
February 20, 2026 0.10
$0.01 (5.67%)
February 19, 2026 0.09
-$0.02 (-18.18%)
February 18, 2026 0.11
$0.01 (10.00%)
February 17, 2026 0.10
$0.01 (8.11%)
February 16, 2026 0.09
$0.00 (0.00%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports